[FATE] QoQ Quarter Result on 30-Sep-2016 [#Q3]

Stock
[FATE] Fate Therapeutics, Inc.
Announcement Date
07-Nov-2016
Financial Year
2016
Quarter
30-Sep-2016 [#Q3]
Profit Trend
QoQ- -3.91%
YoY- -26.88%
Quarter Report
FATE's Result
FATE's Financial Summary
View:
Show?
Quarter Result
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Revenue 1,026 1,027 1,027 1,026 1,027 1,322 1,076 -3.12%
PBT -9,645 -10,126 -7,940 -8,737 -8,408 -8,377 -7,446 18.84%
Tax 137 111 -160 37 31 27 -207 -
NP -9,645 -10,126 -7,940 -8,737 -8,408 -8,377 -7,446 18.84%
Tax Rate - - - - - - - -
Total Cost 10,671 11,153 8,967 9,763 9,435 9,699 8,522 16.18%
Ratio Analysis
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
NP Margin -940.06 -985.98 -773.13 -851.56 -818.70 -633.66 -692.01 22.68%
Per Share
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
EPS -0.23 -0.24 -0.21 -0.27 -0.29 -0.29 -0.26 -7.85%
EPS Diluted -0.23 -0.24 -0.21 -0.27 -0.29 -0.29 -0.26 -7.85%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.